Identification of differential pathways in papillary thyroid carcinoma utilizing pathway co-expression analysis

Area of Science:

• Oncology
• Bioinformatics
• Systems Biology

Background:

• Papillary thyroid carcinoma (PTC) is a common endocrine malignancy.
• Identifying molecular pathways dysregulated in PTC is crucial for developing targeted therapies.
• Novel computational methods are needed to analyze complex pathway interactions.

Purpose of the Study:

• To identify differential pathways between PTC patients and normal controls.
• To develop and apply a novel method combining pathway analysis with co-expression networks.
• To uncover potential biomarkers for PTC detection and treatment.

Main Methods:

• A three-step approach was employed: pathway background pretreatment, construction of a pathway co-expression network using empirical Bayes (EB), and identification of differential pathways using a random model threshold.
• Representative pathways in PTC were identified.
• Pathway weights were assigned using the EB approach.

Main Results:

• 1267 representative pathways were identified with associated weight values.
• 87 differential pathways were identified between PTC patients and normal controls based on a weight threshold (> 0.0296).
• Top differential pathways included CREB phosphorylation, GPI anchor attachment to uPAR, and SMAD2/3 loss of function.

Conclusions:

• The proposed pathway co-expression method successfully identified differential pathways in PTC.
• Identified pathways, such as CREB phosphorylation and GPI-anchored protein synthesis, may serve as potential biomarkers.
• These findings could advance PTC detection and targeted therapy strategies.